Stereotaxis (STXS) Capital Expenditures Growth (1y) (2011 - 2026)
Stereotaxis (STXS) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 127.02 Bn | 121.80 Bn | 1.96 Bn | 17.46% |
| 2 | Becton Dickinson | 44.84 Bn | 44.03 Bn | 2.15 Bn | 9.65% |
| 3 | Alcon | 33.09 Bn | 31.43 Bn | 1.53 Bn | - |
| 4 | Medline | 32.94 Bn | 30.70 Bn | 1.84 Bn | -2.04% |
| 5 | Resmed | 29.41 Bn | 27.75 Bn | 890.98 Mn | 61.83% |
| 6 | West Pharmaceutical Services | 23.25 Bn | 22.82 Bn | 329.20 Mn | -42.55% |
| 7 | Solventum | 14.10 Bn | 13.54 Bn | 1.10 Bn | -22.94% |
| 8 | Cooper Companies | 13.79 Bn | 13.65 Bn | 735.40 Mn | 10.63% |
| 9 | Align Technology | 12.07 Bn | 11.01 Bn | 736.59 Mn | 21.73% |
| 10 | Stereotaxis | 132.02 Mn | 117.40 Mn | 3.79 Mn | 243.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 243.48% |
| Dec 31, 2025 | 3,400.00% |
| Sep 30, 2024 | 0.00% |
| Sep 30, 2023 | -95.12% |
| Jun 30, 2023 | -98.92% |
| Mar 31, 2023 | -69.76% |
| Dec 31, 2022 | -69.15% |
| Sep 30, 2022 | 301.96% |
| Jun 30, 2022 | 460.34% |
| Mar 31, 2022 | 3,294.12% |
| Dec 31, 2019 | 37.53% |
| Sep 30, 2019 | -96.98% |
| Mar 31, 2019 | -1.57% |
| Dec 31, 2018 | 4.56% |
| Sep 30, 2018 | 193.12% |
| Mar 31, 2018 | 132.49% |
| Dec 31, 2015 | 22.43% |
| Sep 30, 2015 | 13.20% |
| Dec 31, 2012 | -98.99% |
| Sep 30, 2012 | -95.22% |